FEATURE ARTICLES
Titanium dioxide (TiO2) is used as a food additive and OSD pharmaceutical excipient. In 2020, the European Food Safety Authority noted data gaps regarding particle size, which can affect its toxicological properties, so the European Commission banned it as a food additive. Here's how this could impact pharma.
- FDA Publishes Final Guidance On Reporting Listed Drug Amounts
- 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
- Managing Supply Chain Risks Using Relational Risk Analysis
- Designing Highly Agile Bio/Pharma Manufacturing Facilities
- A Quality-Led Approach To Drug Production Facility Design
- Quick Takes From Takeda Austria’s Annex 1 Rollout
- Navigating Grades And Sources Of Materials In Drug Manufacturing
PHARMA ONLINE WHITE PAPERS
-
Selecting The Locations Of Particle Monitoring For The Fill-Finish Process
Learn about monitoring viable and non-viable particles during the fill-finish process of drug manufacturing as well as considerations for the location of airborne particle monitors.
-
Recommendations For Successful IND Approval Of RNA-LNP Drugs8/22/2023
The existing regulatory system is ambiguous for RNA therapeutics. Leverage this Investigational New Drug (IND) guide to help accelerate and strengthen the process IND filing of novel nanomedicines.
-
Biological Indicators And The European Pharmacopoeia5/10/2022
Here, we review the information concerning biological indicators in European Pharmacopoeia General Chapter 5.1.2, which is more detailed and covers a wider scope than the previous version.
-
Outstanding Sensitivity For Confident SPR Interaction Analysis7/20/2022
Explore how surface plasmon resonance (SPR)-based analyses with a high sensitivity instrument can provide greater data precision and better confidence in your results interpretation.
-
CCIT Comparative Study Between Dye Ingress And Deterministic Methods1/13/2023
Explore the results of a unique comparative study of CCIT, and find a suitable deterministic test method to replace the blue dye test that follows the latest guidelines.
-
Comparing Single-Use To Fixed Bioprocessing Systems9/1/2023
Several life cycle assessments have been conducted comparing the environmental impact of SUTs to conventional fixed systems, leading to results that could inform changes in bioprocess system use.
PHARMA ONLINE APP NOTES & CASE STUDIES
NEWSLETTER ARCHIVE
- 04.19.24 -- 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies
- 04.18.24 -- Optimizing Drug Delivery Systems For Complex Biologics
- 04.18.24 -- Designing Highly Agile Bio/Pharma Manufacturing Facilities
- 04.17.24 -- Streamline Oligo Production With A Comprehensive Equipment Range
- 04.17.24 -- Next Generation Isolator Technology
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage. Check out the latest e-book from Pharmaceutical Online.
More Content Collections